CRVO · CervoMed Inc. · Documents
$2.33
+0.02 (+0.87%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 7, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 7, 2026Market Cap
$34.93M
Shares
15.12M
Volume · Oct 20
133.34K
Avg daily vol (3M)
286.35K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | CervoMed Inc. made information concerning its business, clinical studies, development plans and financial position available on its website under “Investors – Events and Presentations,” for possible use in investor conferences, meetings and presentations. | 2026-10-14 | — | |
| 8-K | CervoMed reported first 12-week Phase 2a nfvPPA results for Neflamapimod: mean plasma neurofilament light levels declined, with greater declines above median baseline; GFAP was stable and no new safety signals emerged. It plans 24-week biomarker data for November 2026. | 2026-10-13 | 2026-10-12 | |
| 8-K | — | 2026-10-09 | — | |
| 8-K | — | 2026-09-28 | — | |
| 8-K | — | 2026-09-10 | — | |
| Investor Event Transcript | — | 2026-08-11 | 2026-09-30 | |
| 8-K | — | 2026-08-10 | — | |
| 10-Q | — | 2026-08-07 | 2026-06-30 | |
| 8-K | — | 2026-08-04 | — | |
| 8-K | — | 2026-07-14 | — | |
| 8-K | — | 2026-07-09 | — | |
| 8-K | — | 2026-06-22 | 2026-06-18 | |
| 8-K | — | 2026-06-22 | — | |
| 8-K | — | 2026-06-18 | 2026-06-16 | |
| 8-K | — | 2026-06-15 | — | |
| 8-K | — | 2026-06-10 | 2026-06-09 | |
| 8-K | — | 2026-06-09 | 2026-06-08 | |
| 8-K | — | 2026-05-18 | — | |
| 10-Q | — | 2026-05-15 | 2026-03-31 | |
| DEF 14A | — | 2026-04-30 | 2026-06-08 | |
| 8-K | — | 2026-04-22 | — | |
| 8-K | — | 2026-04-07 | — | |
| 8-K | — | 2026-03-23 | — | |
| 8-K | — | 2026-03-19 | — | |
| 8-K | — | 2026-03-17 | — | |
| 10-K | — | 2026-03-13 | 2025-12-31 | |
| 8-K | — | 2026-03-04 | — | |
| 8-K | — | 2026-02-18 | — | |
| 8-K | — | 2026-01-08 | 2026-01-07 | |
| 8-K | — | 2025-12-05 | 2025-12-01 | |
| 8-K | — | 2025-11-10 | — | |
| 10-Q | — | 2025-11-07 | 2025-09-30 | |
| 8-K | — | 2025-11-04 | — | |
| 8-K | — | 2025-10-29 | 2025-10-27 | |
| 8-K | — | 2025-10-22 | — | |
| 8-K | — | 2025-10-08 | — | |
| 8-K | — | 2025-08-11 | — | |
| 10-Q | — | 2025-08-08 | 2025-06-30 | |
| 8-K | — | 2025-08-05 | — | |
| 8-K | — | 2025-07-28 | — | |
| 8-K | — | 2025-06-25 | 2025-06-23 | |
| 8-K | — | 2025-05-19 | — | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | — | |
| DEF 14A | — | 2025-04-29 | 2025-06-23 | |
| 8-K | — | 2025-04-18 | 2025-04-14 | |
| 8-K | — | 2025-04-07 | 2025-04-02 | |
| 8-K | — | 2025-03-18 | 2025-03-17 | |
| 10-K | — | 2025-03-17 | 2024-12-31 | |
| 8-K | — | 2025-03-11 | — |
Showing 1–50 of 192 filings